Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Estrospey
- Development stage
- Unknown
- Lead developer
- Spey Medical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Estrospey is an over-the-counter combination dietary supplement developed by SPEY and manufactured by Pharmacy Lab. It is formulated to support menopausal health and mitigate the physical discomforts associated with declining estrogen levels in women over 40 years of age during perimenopause. The formulation contains a blend of active ingredients, including magnesium, vitamin B1 (thiamine), vitamin B6 (pyridoxine), vitamin C (ascorbic acid), soybean extract (a source of phytoestrogens), and lemon balm (Melissa officinalis) herb extract.
- Brand names
- Estrospey
02
Targets
ER (Estrogen receptor)
Beyond the preview
Go deeper on Estrospey.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Estrospey.